Research use only · Not for human consumption
Los Angeles, CA · Same‑day dispatch
SCALE PEPTIDES Request a portal invite →
Clinical reference

503A pharmacy

Patient-specific compounding under applicable conditions—not a research supply model.

GlossaryUpdated 2026-09-24
01

Patient-specific framework

Section 503A generally ties qualifying compounded drugs to valid patient-specific prescriptions.

02

Applicable conditions

Federal and state requirements apply, including specified conditions for limited anticipatory compounding.

03

Not research supply

Compounded medicine and research material are different. Compounded drugs are not FDA-approved.

The short answer

Section 503A establishes conditions for certain compounded drugs, generally tied to valid patient-specific prescriptions. It applies to qualifying compounding by a licensed pharmacist or physician.

Limited anticipatory compounding can be allowed under specified conditions. This is not a research-supply model, and compounded drugs are not FDA-approved.

What the term describes

A business called a 503A pharmacy is referring to the patient-specific compounding framework. State requirements and federal conditions apply; the label does not establish that every preparation or practice is lawful.

Different from research stock

Compounded medicine and research material have different intended uses and requirements. A research supplier is not a pharmacy, and research vials are not a substitute for patient medication.

Why it appears here

Buyers comparing research supply and clinical businesses may encounter the term. Confirm a provider's actual licensure, products and operating model with qualified advisors.

A useful next step

Research vials are not patient medication.

This term helps distinguish clinical and research businesses. Confirm actual licensure and operating requirements with qualified advisors. Scale is not a pharmacy or clinical service.

Compare the business models →
Continue reading

Compare the business models

Continue with the supporting guidance. Research information does not establish legal clearance or clinical suitability.